โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Etichetta canale medico: 16 negli ultimi 7 giorni ๐ŸŽ Canale alimentare: 193 negli ultimi 7 giorni ๐Ÿงธ Canale: prodotti: 48 negli ultimi 7 giorni ๐ŸŸข Monitoraggio: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Ultimo recupero: 54 minuti fa โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Etichetta canale medico: 16 negli ultimi 7 giorni ๐ŸŽ Canale alimentare: 193 negli ultimi 7 giorni ๐Ÿงธ Canale: prodotti: 48 negli ultimi 7 giorni ๐ŸŸข Monitoraggio: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Ultimo recupero: 54 minuti fa
๐Ÿ›ก๏ธ EUSW
๐Ÿ‡ฎ๐Ÿ‡น
๐Ÿ’Š

Beyfortus

nirsevimab
โœ… Autorizzato
โœ…
Nessun allarme attivo
Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.

A cosa serve

Beyfortus is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in:i.        Neonates and infants during their first RSV season.ii.        Children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season (see section 5.1).Beyfortus should be used in accordance with official recommendations. Beyfortus is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in:i.          Neonates and infants during their first RSV season.ii.         Children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season (see section 5.1).Beyfortus should be used in accordance with official recommendations.

โš ๏ธ Sicurezza del paziente

No

โš ๏ธ Aggregiamo avvisi ufficiali. Non forniamo consulenze mediche. Per decisioni mediche o legali, consulta l'ente di riferimento e un professionista qualificato.